Mit Magzter GOLD unbegrenztes Potenzial nutzen
Erhalten Sie unbegrenzten Zugriff auf über 9.000 Zeitschriften, Zeitungen und Premium-Artikel für nur
Versuchen GOLD - Frei
Merger for bail-out from debt obligation
M & A Critique
|June 2024
Ind Swift Limited (herein after also referred to as 'ISL' or 'Transferor Company') is engaged in the business of manufacturing of Pharmaceutical Products.
ISL is a leading pharmaceutical manufacturer of Finished Dosages Form (FDF) with national and international presence based in Chandigarh. Its strength lies in innovative pharmaceutical products. The Transferor Company is listed on BSE Limited and the National Stock Exchange of India Limited.
Ind Swift Laboratories Limited (herein after also referred to as 'ISLL' or 'Transferee Company') is primarily engaged in inter alia in the business of manufacturing and marketing of Active Pharmaceutical Ingredients (APIs), Intermediates and Finished Dosages through recently set up joint ventures. Recently, ISLL completed transfer of its core API & intermediates business through a slump sale transaction. The Transferee Company is also listed BSE Limited and the National Stock Exchange of India Limited. Currently, ISLL has recently started Finished Dosage Business through joint ventures and surplus cash received through a slump sale. Earlier, ISL was holding 16.08% of equity capital of ISLL which was transferred to other promoter company Essix Biosciences Limited in March 2024 for a consideration of INR 95 crore.
The Transferor Company and Transferee Company belong to the same group i.e., the Ind-swift Group.
Slump Sale by ISLL
Diese Geschichte stammt aus der June 2024-Ausgabe von M & A Critique.
Abonnieren Sie Magzter GOLD, um auf Tausende kuratierter Premium-Geschichten und über 9.000 Zeitschriften und Zeitungen zuzugreifen.
Sie sind bereits Abonnent? Anmelden
WEITERE GESCHICHTEN VON M & A Critique
M & A Critique
Thermo Fisher to buy clinical services provider Clario for up to $9.4 billion
Thermo Fisher said it would buy privately held data management company Clario for up to $9.4 billion, strengthening its clinical trial research business amid a strong rebound in demand in the U.S.
1 min
November 2025
M & A Critique
Cygnet Energy to acquire Kiwetinohk in $1 billion deal
Privately held Cygnet Energy will acquire Kiwetinohk Energy in an all-cash deal valued at C$1.4 billion ($998.29 million), including debt, the companies said, creating a larger Montney and Duvernay operator.
1 min
November 2025
M & A Critique
Boyd Group to acquire Joe Hudson's Collision Center for $1.3 billion
Canada's Boyd Group said it has agreed to acquire autobody repair solutions provider Joe Hudson's Collision Center, or JHCC, from TSG Consumer Partners for $1.3 billion.
1 min
November 2025
M & A Critique
US firm Long Path to buy UK's Idox for $438 million
U.S. investment firm Long Path agreed to take British software provider Idox private in a 339.5million-pound ($438 million) deal, offering shareholders 71.5 pence per share in cash.
1 min
November 2025
M & A Critique
Refex Green Mobility Demerger Analysis and Valuation Concerns
Recently, Refex Industries Limited announced that it will separately list its green mobility business through a series of restructuring steps, a segment the company only began building in 2023. While the move is positioned as a value-creation exercise, the question remains: given its small size and substantial capital needs, can this fledgling business truly hold its ground as an independently listed entity?
3 mins
November 2025
M & A Critique
Jindal Power buys Apraava Energy's Jhajjar power plant
Naveen Jindal-owned Jindal Power Ltd (JPL) has signed an agreement to acquire the 1,350 MW Jhajjar Power Project in Haryana from Apraava Energy (formerly CLP India), marking one of the largest thermal power deals in recent years.
1 mins
November 2025
M & A Critique
Mahindra Group weighs major restructuring; may spin off tractors, PVs & trucks into separate entities
Mahindra Group is evaluating the separation of its core businesses — tractors, passenger vehicles (including EVs), and trucks — into independent entities, in what could mark the conglomerate's most significant restructuring in years, according to people familiar with the matter.
2 mins
November 2025
M & A Critique
Indian Oil's Terra Clean in talks to buy 50% stake in Fourth Partner Energy
Indian Oil Corp., the country's largest crude oil refiner, plans to acquire a 50% stake in renewable energy firm Fourth Partner Energy Pvt. Ltd (FPEL) through its subsidiary Terra Clean Ltd in a deal with an estimated equity value of about $400 million, according to two people aware of the development.
2 mins
November 2025
M & A Critique
Veranda Learning Restructures: Amalgamation followed by 'Commerce Education Business' Demerger
“Veranda Learning Solutions Limited (VLSL) is implementing its 'Veranda 2.0' strategy by carving out its high-growth Commerce Education Business”
5 mins
November 2025
M & A Critique
ASG Eye Hospitals to merge with Sharp Sight in Rs 450 crore deal; PE-backed chain targets IPO
ASG Eye Hospitals, backed by private equity firms General Atlantic and Kedaara Capital, has signed a Rs 450 crore nonbinding merger deal with Sharp Sight Eye Hospitals, said people familiar with the matter.
1 mins
November 2025
Listen
Translate
Change font size